Overview:Molecular testing can inform selection of therapy for patients with NSCLC across the disease continuum. It is critical for clinicians to be up-to-date on the best practices for testing, as well as the various agents at their disposal to exploit these molecular features. This series features expert faculty presenting on the latest findings supporting the inclusion of novel targeted…

Overview:When cytopenia is suspected, a complete diagnostic workup is required to determine its cause, as well as severity, and potential line of treatment. Physicians often lack the granular knowledge from many comparative tests that can be necessary to properly diagnose rare blood disorders, including paroxysmal nocturnal hemoglobinuria (PNH). Furthermore, once a proper diagnosis is determined,…